Faculty

Bonnie Halpern-Felsher

PhD
Professor
Stanford University School of Medicine

Dr. Bonnie Halpern-Felsher is the Marron and Mary Elizabeth Kendrick Professor in Pediatrics II in the Division of Adolescent Medicine, Department of Pediatrics, Stanford University. Dr. Halpern-Felsher is a developmental psychologist with additional training in adolescent and young adult health. She is the founder and executive director of her Stanford REACH Lab as well as several nationally and internationally used substance use education preventions and interventions. She is the receipient of the 2025 American Lung Association Outstanding Mother Award, that recognizes women who balance work and family and make a significant contribution to the mission of the American Lung Association. She was also the receipient of the 2025 Society for Research on Nicotine and Tobacco (SRNT) John Slade award, that recognizes individuals who’s research makes a significant impact on tobacco-related policy. Most recently, she received the 2026 Cullen Award from the American Society of Preventive Oncology. She is also a Past President of the Society for Adolescent Health and Medicine. Funded by the NIH and many foundations, her research has focused on understanding and reducing adolescent and young adult tobacco, marijuana, and other drug use. Her research including over 250 publications, committee, and advocacy work have been instrumental in setting policy at the local, state, and national level. She has served as a consultant to several community-based adolescent health promotion programs, participated in three Surgeon General Reports, participated in six National Academies of Science committees, and has been a member on several national campaigns and committees to understand and reduce adolescent and young adult drug use.

2027 Sessions

Just Say Know! Safety First: A Comprehensive, Harm Reduction-Based, Drug Intervention Curriculum

Session Description: What if youth substance use prevention could move beyond "just say no" and equip young people with the knowledge and skills to make safer, healthier decisions? Developed by the Stanford REACH Lab, Safety First is an innovative, evidence-informed, 13-lesson curriculum that combines prevention, harm reduction, and trauma-informed practices to address cannabis, nicotine/e-cigarettes, alcohol, opioids and fentanyl, hallucinogens, and other drugs. In this highly interactive workshop, participants will explore the principles of harm reduction, examine common misconceptions about adolescent substance use, and experience engaging activities directly from the curriculum. Through small-group discussions and hands-on lesson demonstrations, attendees will discover practical strategies for facilitating honest, science-based conversations that resonate with today's youth while encouraging abstinence as the healthiest choice and providing risk-reduction guidance for students who are already experimenting or using. Participants will also receive a guided tour of the free, online Safety First curriculum and learn how to confidently implement its lessons in classrooms, prevention programs, healthcare settings, and community organizations. The curriculum incorporates media literacy, critical thinking, family engagement, and evidence-based instructional practices that empower youth to evaluate information, reduce risk, and make informed decisions. Attendees will leave with immediately applicable tools, adaptable teaching strategies, and access to free, ready-to-use resources that can strengthen youth prevention efforts and support healthier outcomes in schools and communities. Whether you are an educator, prevention specialist, healthcare professional, or community leader, this session will provide practical, evidence-based approaches you can begin using immediately.

Presenter

Tuesday, March 30 1:15–2:30 PM
1.25 Credits
Prevention
Faculty

Scott Gerbert

MHA
Director, Outreach and Strategic Partnerships
Stanford University School of Medicine, Pediatrics Dept. - REACH Lab

For 30+ years, Mr. Gerbert has been an educator, serving as a teacher, district administrator, and county administrator, leading schools, districts, and county-wide programs around tobacco and cannabis prevention and interventions, along with other health and wellness topics. He has been involved in tobacco prevention efforts in California since 1997 and has been the chair or co-chair for the Alameda County Tobacco Control Coalition for the last 9+ years, as well as being an active member of numerous Drug Free Community (DFC) coalitions. He is also a Director for Rotary International’s Health Education and Wellness Rotary Action Group (HEWRAG), engaging in global health education and wellness work. He joined the team at Stanford's REACH lab in 2022, working to find additional ways to empower and educate communities to combat the Triangulum of tobacco, vaping, and cannabis, along with other health disparities and health inequities. His work centers around improving health and wellness literacy and lifting up youth voice and agency, while decreasing health disparities and health inequities.

Faculty

Bonnie Halpern-Felsher

PhD
Professor
Stanford University School of Medicine

Dr. Bonnie Halpern-Felsher is the Marron and Mary Elizabeth Kendrick Professor in Pediatrics II in the Division of Adolescent Medicine, Department of Pediatrics, Stanford University. Dr. Halpern-Felsher is a developmental psychologist with additional training in adolescent and young adult health. She is the founder and executive director of her Stanford REACH Lab as well as several nationally and internationally used substance use education preventions and interventions. She is the receipient of the 2025 American Lung Association Outstanding Mother Award, that recognizes women who balance work and family and make a significant contribution to the mission of the American Lung Association. She was also the receipient of the 2025 Society for Research on Nicotine and Tobacco (SRNT) John Slade award, that recognizes individuals who’s research makes a significant impact on tobacco-related policy. Most recently, she received the 2026 Cullen Award from the American Society of Preventive Oncology. She is also a Past President of the Society for Adolescent Health and Medicine. Funded by the NIH and many foundations, her research has focused on understanding and reducing adolescent and young adult tobacco, marijuana, and other drug use. Her research including over 250 publications, committee, and advocacy work have been instrumental in setting policy at the local, state, and national level. She has served as a consultant to several community-based adolescent health promotion programs, participated in three Surgeon General Reports, participated in six National Academies of Science committees, and has been a member on several national campaigns and committees to understand and reduce adolescent and young adult drug use.

What's Showing Up Next? Kratom, 7-OH, and Emerging Drug Trends Affecting Youth and Communities

Session Description: The illicit and commercial drug landscape is changing rapidly, with new psychoactive substances appearing in convenience stores, vape shops, online marketplaces, and social media long before many professionals are aware of them. Kratom, concentrated kratom extracts, 7-hydroxymitragynine (7-OH) products, and other emerging substances are increasingly accessible, creating new challenges for prevention, healthcare, education, public safety, and community organizations.This interactive session will provide participants with an evidence-based overview of these rapidly evolving substances, including what they are, how they are marketed, why individuals use them, and what current research tells us about their potential health effects, misuse potential, and relationship to the broader opioid landscape. Presenters will also examine emerging trends in youth and young adult exposure, common misconceptions, and the influence of social media, retail availability, and evolving product formulations. Drawing on the latest scientific research and practical experience working with schools, communities, and prevention organizations, Dr. Bonnie Halpern-Felsher (Stanford University) and Scott Gerbert, MHA, will translate complex research into actionable strategies that attendees can immediately apply within their own settings. Participants will also receive a preview of Stanford University's REACH Lab's new free kratom and 7-hydroxymitragynine (7-OH) prevention curriculum, currently in development, along with information on how these evidence-informed educational resources can support prevention efforts in schools and communities. Whether attendees work in prevention, treatment, healthcare, education, law enforcement, or public health, this session will equip them to recognize emerging trends and respond with confidence using current evidence rather than myths or misinformation.

Presenter

Wednesday, March 31 1:15–2:30 PM
1.25 Credits
Illicit Drugs
Faculty

Scott Gerbert

MHA
Director, Outreach and Strategic Partnerships
Stanford University School of Medicine, Pediatrics Dept. - REACH Lab

For 30+ years, Mr. Gerbert has been an educator, serving as a teacher, district administrator, and county administrator, leading schools, districts, and county-wide programs around tobacco and cannabis prevention and interventions, along with other health and wellness topics. He has been involved in tobacco prevention efforts in California since 1997 and has been the chair or co-chair for the Alameda County Tobacco Control Coalition for the last 9+ years, as well as being an active member of numerous Drug Free Community (DFC) coalitions. He is also a Director for Rotary International’s Health Education and Wellness Rotary Action Group (HEWRAG), engaging in global health education and wellness work. He joined the team at Stanford's REACH lab in 2022, working to find additional ways to empower and educate communities to combat the Triangulum of tobacco, vaping, and cannabis, along with other health disparities and health inequities. His work centers around improving health and wellness literacy and lifting up youth voice and agency, while decreasing health disparities and health inequities.

Faculty

Bonnie Halpern-Felsher

PhD
Professor
Stanford University School of Medicine

Dr. Bonnie Halpern-Felsher is the Marron and Mary Elizabeth Kendrick Professor in Pediatrics II in the Division of Adolescent Medicine, Department of Pediatrics, Stanford University. Dr. Halpern-Felsher is a developmental psychologist with additional training in adolescent and young adult health. She is the founder and executive director of her Stanford REACH Lab as well as several nationally and internationally used substance use education preventions and interventions. She is the receipient of the 2025 American Lung Association Outstanding Mother Award, that recognizes women who balance work and family and make a significant contribution to the mission of the American Lung Association. She was also the receipient of the 2025 Society for Research on Nicotine and Tobacco (SRNT) John Slade award, that recognizes individuals who’s research makes a significant impact on tobacco-related policy. Most recently, she received the 2026 Cullen Award from the American Society of Preventive Oncology. She is also a Past President of the Society for Adolescent Health and Medicine. Funded by the NIH and many foundations, her research has focused on understanding and reducing adolescent and young adult tobacco, marijuana, and other drug use. Her research including over 250 publications, committee, and advocacy work have been instrumental in setting policy at the local, state, and national level. She has served as a consultant to several community-based adolescent health promotion programs, participated in three Surgeon General Reports, participated in six National Academies of Science committees, and has been a member on several national campaigns and committees to understand and reduce adolescent and young adult drug use.

Back to top